اپولو ہسپتال، لکھنؤ میں سائٹورڈکٹیو سرجری

Cytoreductive surgery (CRS), often combined with hyperthermic intraperitoneal chemotherapy (HIPEC), is one of the most demanding operations in surgical oncology. It needs a dedicated peritoneal surface malignancy team, high-dependency and intensive care backup, blood bank support, stoma and nutrition services, and an anaesthesia team experienced in long abdominal procedures. Apollo Hospitals Lucknow offers this care within a multi-specialty tertiary set-up so that surgical oncology, medical oncology, radiation oncology, gastroenterology, critical care and rehabilitation work under one roof.

• 1983 سے اپولو ہسپتالوں کی گروپ کی میراث ? India's first corporate hospital chain, with a group-wide network of hospitals, cancer centres and a large multidisciplinary oncology workforce; Apollo Hospitals Lucknow serves as a tertiary referral centre for central and eastern Uttar Pradesh.
• Multidisciplinary tumour board approach ? surgical oncologists, medical oncologists, radiation oncologists, radiologists, pathologists, anaesthetists and intensivists jointly decide whether cytoreduction is appropriate, rather than a single-surgeon decision. This matters because patient selection, not surgical enthusiasm, drives outcomes in CRS.
• Full-spectrum surgical oncology team ? the exact number of consultants and their combined years of experience for the Lucknow unit is published on the hospital's own doctor listing and confirmed by the oncology coordinator at the time of booking; ask for the treating team's specific CRS/HIPEC caseload during your consultation.
• Diagnostic and imaging depth ? CT, MRI and PET-CT for peritoneal cancer index (PCI) assessment, image-guided biopsy, diagnostic laparoscopy for staging, and frozen-section pathology during surgery.
• Peri-operative infrastructure ? modular operation theatres, HIPEC perfusion capability, intensive care and high-dependency beds, 24x7 blood bank and transfusion support, and round-the-clock lab and radiology services, all of which are non-negotiable for a 6?12 hour operation.
• Supportive care built in ? clinical nutrition and dietetics, stoma care counselling, physiotherapy and pulmonary rehabilitation, pain and palliative care, and psycho-oncology support for the patient and family.
• Continuity across the cancer pathway ? the same institution delivers neoadjuvant and adjuvant chemotherapy, targeted or maintenance therapy where indicated, radiation therapy if needed, and long-term surveillance imaging, so records and follow-up stay in one place.
• Care pathways adapted by age and fitness ? separate pre-habilitation and recovery plans for younger adults returning to work or sport, for older patients with cardiac, renal or diabetic comorbidity, and referral pathways for paediatric and adolescent abdominal tumours to paediatric surgical oncology.
• سائٹ پر انشورنس اور TPA ڈیسک ? assistance with pre-authorisation, cashless approvals, CGHS/ECHS/Ayushman-type scheme eligibility checks where applicable, and documentation for reimbursement claims.
• Accessible to out-of-town families ? a single-window oncology coordinator, consolidated same-visit investigations where feasible, and guidance on nearby stay for patients travelling from districts across Uttar Pradesh, Bihar, Nepal border areas and Uttarakhand.

جائزہ

Cytoreductive surgery is a specialised surgical procedure aimed at removing as much of a tumour as possible, particularly in cases of advanced cancer. At Apollo Hospitals Lucknow, we pride ourselves on our reputation for excellence in cancer care, using current technology and established techniques to work towards the best achievable outcomes for our patients. Our team of skilled surgeons and oncologists is dedicated to delivering personalised care, ensuring that each patient receives careful attention and appropriate expertise. With a focus on patient trust and transparent communication, Apollo Hospitals Lucknow is a recognised referral centre for complex cancer surgery in the region.

In practice, "cytoreduction" means systematically removing visible tumour deposits from the peritoneum (the lining of the abdominal cavity) and, where necessary, resecting involved organs or segments of bowel, omentum, spleen, gallbladder, diaphragmatic peritoneum or pelvic structures. The aim of a complete cytoreduction is to leave no visible residual disease. When that is achievable in carefully selected patients, published series report meaningfully better long-term outcomes than with chemotherapy alone ? though results vary widely by tumour type, disease extent and patient fitness.

سائٹورڈکٹیو سرجری کیوں ضروری ہے۔

Cytoreductive surgery is often a critical component of cancer treatment, particularly for patients with advanced-stage tumours. The primary goal of this procedure is to reduce the tumour burden, which can lead to improved survival and better quality of life in appropriately selected patients. By removing as much of the cancerous tissue as possible, cytoreductive surgery can improve the effectiveness of subsequent treatments such as chemotherapy or, in selected cases, radiation therapy.

In many cases, this surgery is performed in conjunction with hyperthermic intraperitoneal chemotherapy (HIPEC), a technique that delivers heated chemotherapy directly into the abdominal cavity after the tumour has been surgically removed. This combination approach has shown promising results in treating cancers such as ovarian cancer, peritoneal mesothelioma, pseudomyxoma peritonei, and colorectal cancer with peritoneal carcinomatosis. The strength of evidence differs by cancer type, and your team will explain where the data are strong and where they are still evolving.

Who Is Considered a Candidate

Selection is the single most important determinant of benefit. Broadly, an assessment considers:

• ٹیومر کی قسم ? pseudomyxoma peritonei and appendiceal mucinous neoplasms, colorectal peritoneal metastases, epithelial ovarian and fallopian tube cancer, malignant peritoneal mesothelioma, and selected gastric cancers with limited peritoneal disease.
• Extent of peritoneal disease ? measured using the Peritoneal Cancer Index on imaging and confirmed at diagnostic laparoscopy or laparotomy.
• Likelihood of complete cytoreduction ? graded by the Completeness of Cytoreduction (CC) score; the benefit of HIPEC is greatest when CC-0 or CC-1 is achieved.
• Absence of extensive disease outside the abdomen, and absence of extensive small bowel or mesenteric root involvement or multi-level bowel obstruction.
• Patient fitness ? performance status, cardiac and pulmonary reserve, renal function, nutritional status, haemoglobin and albumin, and control of diabetes or hypertension.
• Response to systemic chemotherapy, where neoadjuvant treatment has already been given.

Some patients who initially appear unsuitable become candidates after systemic chemotherapy, nutritional optimisation, iron or blood transfusion, glycaemic control, smoking and tobacco cessation, and pre-habilitation. Others are better served by chemotherapy alone or by best supportive care, and an honest discussion about this is part of good practice.

موجودہ گائیڈ لائن پوزیشن

Recommendations relevant to cytoreductive surgery and HIPEC come from several recognised bodies, and Indian practice reflects them alongside national consensus statements:

• Indian Society of Peritoneal Surface Malignancies (ISPSM) has published consensus and expert guidance on patient selection, PCI and CC scoring, credentialing of centres, and peri-operative management for CRS and HIPEC in the Indian context, including its collaborative work published in Indian oncology and surgical oncology journals.
• National Cancer Grid (NCG) India ? Management Guidelines (updated periodically; the current edition is available on the NCG portal) address peritoneal surface malignancy, recommending CRS ? HIPEC only in selected patients at experienced high-volume centres with multidisciplinary review, and cautioning against routine use outside those settings.
• Association of Gynecologic Oncologists of India (AGOI) / FOGSI guidance and international bodies support interval debulking with HIPEC in stage III epithelial ovarian cancer after neoadjuvant chemotherapy in fit patients ? a position strengthened by the OVHIPEC trial and its long-term follow-up, and reflected in current NCCN Ovarian Cancer guidelines, which list HIPEC at interval debulking as an option rather than a universal standard.
• Colorectal peritoneal metastases: practice changed after the PRODIGE 7 trial, which found no survival benefit from adding oxaliplatin-based HIPEC to complete cytoreduction. Current guidance therefore emphasises complete cytoreductive surgery as the therapeutic core, with HIPEC used selectively and discussed as being of uncertain incremental benefit for colorectal primaries. This is one of the most important recent changes in the field.
• گیسٹرک کینسر: prophylactic and therapeutic HIPEC remains investigational in most guidelines, appropriate mainly within trials or highly selected protocols.
• Enhanced Recovery After Surgery (ERAS) Society guidelines for cytoreductive surgery and HIPEC support structured pre-habilitation, carbohydrate loading where safe, goal-directed fluid therapy, multimodal and epidural analgesia, early mobilisation and early enteral nutrition.

Guidelines are revised regularly, and the recommendation that applies to you depends on your tumour type, disease extent and fitness. Ask your treating oncologist which guideline and which edition their recommendation is based on.

تاخیر کے خطرات

Delaying cytoreductive surgery can have serious consequences. As tumours grow, they can invade surrounding tissues and organs, making surgical removal more complex and less likely to be complete. A rising peritoneal cancer index reduces the chance of achieving CC-0 cytoreduction, and extensive small bowel involvement can make the operation impossible altogether. Delay also raises the risk of bowel obstruction, ureteric obstruction, ascites, malnutrition and deconditioning ? each of which further reduces surgical candidacy.

Timely intervention is therefore important. At Apollo Hospitals Lucknow, we aim to provide prompt consultations, expedite staging investigations, and present a clear treatment plan after multidisciplinary discussion. That said, "timely" does not mean rushed: in several cancers the correct sequence is chemotherapy first, then surgery, and moving too fast can be as harmful as waiting too long.

Cytoreductive سرجری کے فوائد

Undergoing cytoreductive surgery can offer meaningful benefits for selected patients with advanced cancer:

• Tumour reduction: significant reduction of tumour mass, which can relieve symptoms and improve general wellbeing.
• Improved treatment efficacy: reducing tumour burden can make subsequent systemic treatment more effective.
• زندگی کا بہتر معیار: many patients experience relief from pain, abdominal distension, early satiety and gastrointestinal symptoms after surgery.
• Better survival in selected groups: published series and randomised data in specific cancers report improved survival with complete cytoreduction compared with systemic treatment alone. Benefit is greatest when no visible disease is left behind, and it is not guaranteed for any individual.
• ذاتی دیکھ بھال: at Apollo Hospitals Lucknow, treatment plans are tailored to each patient's tumour biology, disease extent, comorbidity and personal priorities.

تیاری اور بحالی

Preparing for cytoreductive surgery involves several important steps to support a smooth process and optimal recovery.

تیاری کے نکات

• مشاورت: schedule a thorough consultation with the surgical team to discuss your medical history, current health status and any concerns.
• آپریشن سے پہلے کی جانچ: complete the required tests, including blood work, imaging studies and other evaluations recommended by your physician.
• ادویات کا انتظام: discuss all current medicines. Some ? particularly blood thinners, certain diabetes medicines and some herbal or Ayurvedic supplements ? may need to be adjusted or stopped before surgery.
• غذائی ایڈجسٹمنٹ: follow the dietary and fasting instructions given by your care team, including any bowel preparation.

ریکوری ٹپس

• Follow postoperative instructions: adhere to the postoperative care plan, including wound care and activity restrictions.
• درد کے انتظام: use the prescribed analgesia protocol and report inadequate pain control early.
• سرگرمیوں میں بتدریج واپسی: resume normal activity progressively, as advised by your surgeon.
• باقاعدہ پیروی: attend every scheduled review so that recovery is monitored and complications addressed early.

At Apollo Hospitals Lucknow, we support patients through the whole surgical journey, from preparation to recovery.

Timing of Surgery and the Pre-procedure Preparation Phase

CRS is almost never an emergency operation. The weeks before surgery are used deliberately.

Technique and Treatment Options Compared

Additional Procedures Sometimes Performed at the Same Time

Because cytoreduction follows the disease rather than a fixed plan, the operation may include:

• Total or partial omentectomy and peritonectomy of the pelvic, paracolic or diaphragmatic surfaces
• Small or large bowel resection with anastomosis, or a temporary ileostomy or colostomy
• Appendicectomy, cholecystectomy or splenectomy
• Hysterectomy with bilateral salpingo-oophorectomy in gynaecological cancers
• Partial gastrectomy, partial liver resection or distal pancreatectomy in selected cases
• Diaphragm resection with repair, and chest drain placement if the pleural cavity is opened
• Ureteric stenting, partial bladder resection or ureteric reimplantation
• Lymph node sampling or dissection, feeding jejunostomy, and epidural catheter placement for analgesia
• Central venous line or chemotherapy port insertion for subsequent systemic treatment

These possibilities are explained during consent, because some ? particularly a stoma or splenectomy ? have long-term implications for daily life and vaccination.

فیز بائی فیز ریکوری

معمول کی سرگرمی، کام اور کھیل کی طرف لوٹنا

Progression is judged by how you are doing, not by the calendar alone. Common criteria before advancing:

• چلنا: encouraged from the first days; aim for short, frequent indoor walks that lengthen weekly.
• ڈرائیونگ: only when you can perform an emergency stop without guarding the wound, are off sedating painkillers, and can turn to check blind spots ? often around 4?6 weeks after a large laparotomy.
• Desk or seated work: frequently possible at 4?8 weeks; work from home earlier if fatigue allows.
• Manual or field work, farming, long two-wheeler travel: usually deferred to 10?12 weeks or beyond, and reviewed individually.
• لفٹنگ: avoid loads above 4?5 kg for at least 6 weeks; avoid heavy lifting and abdominal straining for 3 months to protect the midline wound from incisional hernia.
• بیٹھنا، ٹانگوں پر بیٹھنا اور فرش پر سونا: these matter greatly in Indian homes. Squatting and Indian-style toilets load the abdominal wall; use a Western commode or a commode chair over the Indian pan for at least 6?8 weeks, and keep a grab bar or sturdy stool for support. Sitting cross-legged on the floor is generally allowed once it is comfortable, but rise using your arms and legs, not by curling the abdomen. If the household sleeps on the floor, use a firm mattress raised on a cot for the first 6?8 weeks so that getting up does not strain the wound.
• Religious and social activity: temple visits, long journeys, weddings and fasting should be planned around energy levels; discuss fasting (including Navratri, Ramzan or Ekadashi fasts) with your dietitian and oncologist, especially during chemotherapy.
• Gym and sport: light stationary cycling and walking from around 6 weeks; core and resistance work only after clearance, usually 3 months; contact sport and heavy weightlifting later still, and only if there is no hernia or wound concern.
• جنسی سرگرمی: resume when comfortable and after review, particularly after pelvic or gynaecological resections.

Reducing the Risk of Recurrence and Staying Under Surveillance

No lifestyle measure prevents recurrence reliably, and honest counselling avoids false reassurance. What does help is disciplined follow-up and general health optimisation:

• Complete the full course of planned chemotherapy, targeted therapy or maintenance therapy, including PARP inhibitors or bevacizumab where prescribed for ovarian cancer.
• Keep every surveillance appointment ? typically clinical review with tumour markers every 3?4 months for the first 2 years, then less often, with CT imaging at intervals set by your oncologist.
• Genetic counselling and BRCA or Lynch syndrome testing where indicated, which also affects screening advice for family members.
• Stop tobacco in all forms, including gutkha, khaini and bidi, and stop alcohol.
• Maintain adequate protein intake, a balanced diet with fruit, vegetables, dal and whole grains, and a healthy weight.
• Regular moderate physical activity once cleared, plus diabetes and blood pressure control.
• Vaccination as advised, especially pneumococcal, meningococcal and influenza cover after splenectomy.
• Report new abdominal pain, persistent vomiting, unexplained weight loss, increasing girth or a rising tumour marker promptly rather than waiting for the next appointment.

Children, Adolescents and Older Adults

بچوں اور نوجوانوں

Peritoneal surface malignancy is uncommon in children. When cytoreduction is considered ? for example in desmoplastic small round cell tumour, some sarcomas or germ cell tumours ? care is led by paediatric surgical and medical oncology, with weight-based chemotherapy dosing, careful attention to growth, fertility preservation counselling for adolescents, schooling continuity, and parental consent with age-appropriate assent from the child. Nutritional support and pain management protocols differ from those used in adults.

پرانے بالغ

Age alone does not disqualify a patient, but physiological reserve does. Older patients undergo a geriatric-oriented assessment covering frailty, nutrition, cognition, falls risk, polypharmacy, cardiac and renal function, and home support. Where reserve is limited, options include a less extensive cytoreduction, surgery without HIPEC, chemotherapy alone, or symptom-directed care. Post-operative priorities include delirium prevention, early mobilisation, cautious fluid management, constipation and pressure-area care, and a realistic discussion with the family about what recovery will demand.

Joint family caregiving

Recovery from CRS needs weeks of hands-on help. In joint families this is often easier, but it works best when responsibilities are assigned: one person as the primary attendant during hospital stay, one for medicines and appointment records, one for finances and insurance paperwork, and a rotation for night care at home. Stoma care, drain observation, wound dressing and diet preparation should be taught to at least two family members before discharge, not one.

If You Choose Not to Have the Surgery

Declining cytoreductive surgery is a legitimate choice, and it should be an informed one. Without surgery:

• Systemic chemotherapy, targeted therapy or immunotherapy may still control disease for a period, though peritoneal deposits often respond less completely than disease elsewhere.
• Peritoneal disease commonly progresses to cause abdominal distension, ascites requiring repeated drainage, early satiety, weight loss, and eventually bowel obstruction.
• Obstruction may later require emergency surgery under far less favourable conditions, or a palliative stoma or stent.
• Palliative care, nutritional support, pain management and home nursing can maintain comfort and dignity, and can be started at any stage alongside other treatment.
• You may seek a second opinion at another high-volume peritoneal surface malignancy centre, and taking your imaging discs, histopathology blocks and slides with you will make that opinion more useful.

Factors That Influence the Cost of Treatment

Cytoreductive surgery is a high-complexity procedure and the total cost varies widely between patients. Apollo Hospitals Lucknow provides a written estimate after clinical assessment. For any figure applicable to your case, please speak to the billing counter or the insurance desk.

Insurance, Cashless Treatment and Scheme Cover in India

• Cashless versus reimbursement: if Apollo Hospitals Lucknow is in your insurer's or TPA's network, planned cashless admission can usually be arranged. Otherwise you pay and claim reimbursement afterwards. The insurance desk will confirm network status for your specific policy.
• Pre-authorisation for planned surgery: submit the policy and ID documents, doctor's advice note, diagnosis, planned procedure and estimate at least 3?7 working days before admission. Approvals for CRS/HIPEC often need detailed clinical justification, so start early.
• انتظار کی مدت: most indemnity health policies carry an initial waiting period of around 30 days for illness, and pre-existing disease waiting periods commonly ranging from 24 to 48 months depending on the product. Some policies also have specific waiting periods for named conditions. Cancer diagnosed or with symptoms present before the policy start date may be treated as pre-existing ? this is decided by the insurer, not the hospital.
• حادثہ بمقابلہ منصوبہ بند احاطہ: accidental injury is typically covered from day one, whereas planned cancer surgery is subject to the waiting periods and disclosure history in your policy. Cytoreductive surgery is a planned procedure and is assessed accordingly.
• Critical illness and cancer-specific plans: these pay a lump sum on diagnosis of a covered cancer stage and are separate from hospitalisation cover; they usual